参考文献/References:
[1] Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma[J]. N Engl J Med, 2008, 359: 378 - 390.
[2] Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J]. Lancet Oncol, 2009, 10: 25 - 34.
[3] Azad NS, Aragon-Ching JB, Dahut WL, et al. Hand-foot skin reactionincreases withcumulative sorafenib dose and with combination anti-vascaular endothelial growth factor therapy[J]. Clin Cancer Res, 2009, 15: 1411 - 1416.
相似文献/References:
[1]任克,陈淑杰,姜德军,等.保尔佳治疗晚期肝癌疼痛两种用药方式的疗效观察[J].介入放射学杂志,1997,(04):226.
[2]王邦浩.影响肝癌介入治疗效果的因素及对策[J].介入放射学杂志,1998,(03):170.
[3]高文斌,刘伟,戚晓军,等.晚期原发性肝癌介入治疗方法评价[J].介入放射学杂志,1998,(03):172.
[4]刘淑惠.肝癌介入治疗的观察与护理[J].介入放射学杂志,1999,(01):46.
[5]周洪超,王冬,徐涛,等.晚期肝癌介入综合治疗评价(附38例报告)[J].介入放射学杂志,1999,(01):44.
[6]陈伟敏,罗佐权.肝癌肝动脉灌注化疗与静脉输注硫代硫酸钠的“双路”疗法18例报告[J].介入放射学杂志,1992,(01):26.
[7]牛树茂,徐元贞,赵殿有,等.肝动脉灌注化疗后引起带状疱疹样皮疹六例报告[J].介入放射学杂志,1994,(01):54.
[8]胡挽华,于明,苏冠琴,等.晚期肝癌CT导向下非血管性介入治疗12例分析[J].介入放射学杂志,1996,(01):41.
[9]叶更新,曾文,杜德坤,等.肝动脉栓塞与经皮碘油标记酒精注射联合治疗晚期肝癌[J].介入放射学杂志,1996,(01):42.
[10]陈勇,李彦豪,黄信华,等.经皮左锁骨下动脉PCS植入术治疗晚期肝癌[J].介入放射学杂志,1996,(01):48.